News
Median Technologies to Showcase iCRO’s Central and AI-Powered Imaging Services for Oncology Clinical Trials at ASCO 2025
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software
Dassault Systèmes and the FondaMental Foundation Launch a Sovereign and Secured Nationwide Health Data Warehouse in France Dedicated to Psychiatry
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and the FondaMental Foundation today announced their collaboration to deploy a nationwide Health Data Warehouse (HDW) in France dedicated to
Median Technologies submits U.S. application for 510(k) clearance of eyonis® LCS
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software
Correction of a release from 12.05.2025 17:37 CET/CEST - Revenue for Q1 2025: 19.7 M€, up +36.5%
Median Technologies to Present Scientific Posters on eyonis® LCS in Two Major Health Conferences in North America in May 2025
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software
BILENDI: Q1 2024 revenues up +4.6% at €14.5 million
Median Technologies Reports Full-year 2024 Financial Results
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis™, a suite of artificial intelligence (AI) powered Software
Median Technologies Reports 2025 Q1 Key Financial Indicators and Provides an Update on Q1 Key Operational Achievements
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”), manufacturer of eyonis™, a suite of artificial intelligence (AI) powered Software
Dassault Systèmes and Airbus Extend Strategic Partnership to Use Virtual Twins for Next-Generation Programs
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Airbus have extended their long-term strategic partnership, putting the 3DEXPERIENCE platform at the heart of lifecycle management of
Verimatrix und AgileTV schließen sich zusammen, um schnell wachsende TVaaS-Lösung zu sichern
Regulatorische Nachrichten:
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheit mit Fokus auf den Menschen für die moderne vernetzte Welt, gab heute eine erweiterte
Verimatrix and AgileTV Partner to Secure Fast-Growing TVaaS Solution
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced expanded collaboration with Bilbao
eyonis™ LCS, Median Technologies’ AI-Powered Software as a Medical Device for Lung Cancer Screening, Confirmed Efficacy and Safety in RELIVE Pivotal Study
Regulatory News:
Median Technologies (Paris:ALMDT) (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”), manufacturer of eyonis™, a suite of artificial intelligence (AI)
Medidata Launches the Site Insights Program to Elevate the Site Voice for Trials
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that it has introduced its Medidata Site Insights Program, a
Correction of a release from 26.03.2025 17:37 CET/CEST - BILENDI: Record results in 2024
Verimatrix führt XTD Velocity Partner Alliance ein, um den weltweiten Vertrieb über Kanäle zu beschleunigen
Regulatorische Nachrichten:
Verimatrix (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute den Start der Verimatrix XTD Velocity Partner
Verimatrix Launches XTD Velocity Partner Alliance to Accelerate Global Channel Sales
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the launch of the Verimatrix XTD Velocity
Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience With Investment in Click Therapeutics for Digital Therapeutics Beyond Clinical Trials
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics and software-enhanced drug therapies
New AR Experience from Dassault Systèmes Transforms Parisian Monuments with Sustainable Energy Innovations
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced “Energy Experience,” its immersive augmented reality experience that transforms Parisian monuments by showcasing sustainable
Dassault Systèmes and RWTH Aachen University Partner to Shape the Systems Engineering Skills of the Future Workforce
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its 10-year collaboration with the Chair and Institute for Machine Elements & Systems Engineering (MSE) at the RWTH Aachen
Prodware: Significant progress in 2024 performance indicators
Dassault Systèmes Enters the Next Phase of Its Living Heart Project with AI-Powered Virtual Twins
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that a beta test is underway to evaluate a new generation of the Living Heart model that can be highly customized for
Median Technologies to Present at TD Cowen’s 45th Annual Health Care Conference
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software
BILENDI: Bilendi in 2024: a year of transformation and major strategic breakthroughs